Quantcast

Alpha-lipoic acid activates dimethylarginine dimethylaminohydrolase in cultured endothelial cells.

Research paper by Woo Je WJ Lee, Seung-Whan SW Kim, Seung-Hwan SH Kim, Geun Hyang GH Kim, Sung Min SM Han, Jong Chul JC Won, Chang Hee CH Jung, Hye-Sun HS Park, Do Sook do S Choi, Ki-Up KU Lee, Joong-Yeol JY Park

Indexed on: 07 Jul '10Published on: 07 Jul '10Published in: Biochemical and Biophysical Research Communications



Abstract

Asymmetric dimethylarginine (ADMA) is a risk factor of cardiovascular diseases. alpha-Lipoic acid (ALA) was shown to improve vascular dysfunction, and to decrease plasma ADMA level. In this study, we investigated whether ALA activates dimethylarginine dimethylaminohydrolase (DDAH), the metabolizing enzyme of ADMA, in cultured endothelial cells. ALA significantly decreased ADMA level in culture media of endothelial cells. ALA increased the gene expression and activity of DDAH, and signal transducer and activator of transcription (STAT)3 phosphorylation. Transfection of STAT3 increased DDAH II promoter activity, and ALA amplified it. ALA-induced increase in DDAH II promoter activity was attenuated in the promoter that had mutation in putative STAT3-binding site. These results suggest that ALA reduces ADMA level by enhancing DDAH activity and DDAH II gene expression, thus providing a novel mechanism by which ALA regulates endothelial function.